R. Coleman, U. Matulonis, D. Lorusso, A. Oaknin, S. Pignata, H. Denys, N. Colombo, T. Gorp, J. Konner, M. Marin, P. Harter, C. Murphy, Jiuzhou Wang, Elizabeth Noble, B. Esteves, M. Method
{"title":"mirvetuximab soravtansine在高叶酸受体α表达的卵巢癌患者中的临床获益:来自soraya研究的结果","authors":"R. Coleman, U. Matulonis, D. Lorusso, A. Oaknin, S. Pignata, H. Denys, N. Colombo, T. Gorp, J. Konner, M. Marin, P. Harter, C. Murphy, Jiuzhou Wang, Elizabeth Noble, B. Esteves, M. Method","doi":"10.1136/ijgc-2022-igcs.30","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":312680,"journal":{"name":"Focused Plenary Abstracts","volume":"24 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"O028/#376 Clinical benefit of mirvetuximab soravtansine in ovarian cancer patients with high folate receptor alpha expression: results from the soraya study\",\"authors\":\"R. Coleman, U. Matulonis, D. Lorusso, A. Oaknin, S. Pignata, H. Denys, N. Colombo, T. Gorp, J. Konner, M. Marin, P. Harter, C. Murphy, Jiuzhou Wang, Elizabeth Noble, B. Esteves, M. Method\",\"doi\":\"10.1136/ijgc-2022-igcs.30\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":312680,\"journal\":{\"name\":\"Focused Plenary Abstracts\",\"volume\":\"24 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Focused Plenary Abstracts\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/ijgc-2022-igcs.30\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Focused Plenary Abstracts","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ijgc-2022-igcs.30","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
O028/#376 Clinical benefit of mirvetuximab soravtansine in ovarian cancer patients with high folate receptor alpha expression: results from the soraya study